Should I buy or sell Zimmer Biomet stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ZBH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZBH, but not buy additional shares or sell existing shares. View ZBH analyst ratings or view top-rated stocks .

What is Zimmer Biomet's stock price target for 2024?

15 Wall Street research analysts have issued 12-month target prices for Zimmer Biomet's stock. Their ZBH share price targets range from $120.00 to $172.00. On average, they expect the company's share price to reach $139.39 in the next year. This suggests a possible upside of 12.4% from the stock's current price. View analysts price targets for ZBH or view top-rated stocks among Wall Street analysts .

How have ZBH shares performed in 2024?

Zimmer Biomet's stock was trading at $121.70 at the beginning of the year. Since then, ZBH shares have increased by 1.9% and is now trading at $124.00. View the best growth stocks for 2024 here .

When is Zimmer Biomet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our ZBH earnings forecast .

How can I listen to Zimmer Biomet's earnings call?

Zimmer Biomet will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link .

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) issued its quarterly earnings results on Thursday, February, 8th. The medical equipment provider reported $2.20 earnings per share for the quarter, beating analysts' consensus estimates of $2.15 by $0.05. The medical equipment provider earned $1.94 billion during the quarter, compared to analyst estimates of $1.93 billion. Zimmer Biomet had a net margin of 13.85% and a trailing twelve-month return on equity of 12.79%. The firm's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.88 EPS. Read the conference call transcript .

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet declared a quarterly dividend on Wednesday, February 21st. Stockholders of record on Friday, March 29th will be given a dividend of $0.24 per share on Tuesday, April 30th. This represents a $0.96 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date of this dividend is Wednesday, March 27th. Read our dividend analysis for ZBH .

Is Zimmer Biomet a good dividend stock?

Zimmer Biomet (NYSE:ZBH) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.77%. The dividend payout ratio is 19.63%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ZBH will have a dividend payout ratio of 11.02% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for ZBH .

What ETFs hold Zimmer Biomet's stock?

ETFs with the largest weight of Zimmer Biomet (NYSE:ZBH) stock in their portfolio include Leatherback Long/Short Alternative Yield ETF (LBAY) , American Century Focused Large Cap Value ETF (FLV) , Goldman Sachs Future Health Care Equity ETF (GDOC) , VanEck Morningstar Wide Moat ETF (MOAT) , Simplify Health Care ETF (PINK) , iShares U.S. Medical Devices ETF (IHI) , VanEck Morningstar ESG Moat ETF (MOTE) and VanEck Vectors Morningstar Global Wide Moat ETF (GOAT) .

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet updated its FY 2024 earnings guidance on Thursday, February, 8th. The company provided EPS guidance of 8.000-8.150 for the period, compared to the consensus earnings per share estimate of 7.940. The company issued revenue guidance of $7.7 billion-$7.8 billion, compared to the consensus revenue estimate of $7.7 billion.

What is Bryan Hanson's approval rating as Zimmer Biomet's CEO?

240 employees have rated Zimmer Biomet Chief Executive Officer Bryan Hanson on Glassdoor.com . Bryan Hanson has an approval rating of 87% among the company's employees. 66.0% of employees surveyed would recommend working at Zimmer Biomet to a friend.

What other stocks do shareholders of Zimmer Biomet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T) , Walt Disney (DIS) , Johnson & Johnson (JNJ) , Bristol-Myers Squibb (BMY) , Cisco Systems (CSCO) , Merck & Co., Inc. (MRK) , Intel (INTC) , AbbVie (ABBV) , NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM) .

Who are Zimmer Biomet's major shareholders?

Zimmer Biomet's stock is owned by a variety of retail and institutional investors. Top institutional investors include Douglas Lane & Associates LLC (0.25%), Matrix Asset Advisors Inc. NY (0.05%), Thomasville National Bank (0.04%), ST Germain D J Co. Inc. (0.04%), Factory Mutual Insurance Co. (0.04%) and Centre Asset Management LLC (0.04%). Insiders that own company stock include Arthur J Higgins, Arthur J Higgins , Betsy J Bernard , Chad F Phipps , Michael W Michelson , Robert Hagemann , Sang Yi , Sreelakshmi Kolli and Zuilen Wilfred Van . View institutional ownership trends .

How do I buy shares of Zimmer Biomet?

Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Zimmer Biomet have any subsidiaries?

The following companies are subsidiares of Zimmer Biomet: Abbott Spine, Beijing Montagne Medical Device Co. Ltd., Beijing Montagne Medical Device Co. Ltd., BioMet, Biomet 3i Australia Pty. Ltd., Biomet 3i Belgium N.V., Biomet 3i Benelux Holdings N.V., Biomet 3i Dental Iberica SL, Biomet 3i LLC, Biomet 3i Mexico S.A. de C.V., Biomet 3i Netherlands B.V., Biomet 3i Nordic AB, Biomet 3i Portugal Lda, Biomet 3i Switzerland GmbH, Biomet 3i Turkey, Biomet 3i UK Ltd., Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda., Biomet Acquisitions (Unlimited), Biomet Argentina SA, Biomet Australia Pty. Ltd., Biomet Biologics LLC, Biomet Brazil Medical Device Ltda., Biomet C.V., Biomet CV Holdings LLC, Biomet Cementing Technologies AB, Biomet Chile SA, Biomet China Co. Ltd., Biomet Deutschland GmbH, Biomet Deutschland Holding GmbH, Biomet Fair Lawn LLC, Biomet Finance US LLC, Biomet France Sarl, Biomet Global Supply Chain Center B.V., Biomet Healthcare Management GmbH, Biomet Holdings B.V., Biomet Hong Kong CBT Ltd., Biomet Hong Kong Holding Ltd., Biomet Hong Kong No. 1 Ltd., Biomet Inc., Biomet Insurance Ltd., Biomet International Inc., Biomet International Orthopedics LLC, Biomet Leasing Inc., Biomet Manufacturing LLC, Biomet Mexico S.A. de C.V., Biomet Microfixation B.V., Biomet Orthopedics LLC, Biomet Orthopedics Puerto Rico Inc., Biomet Spain Orthopaedics S.L., Biomet Sports Medicine LLC, Biomet Trauma LLC, Biomet U.S. Reconstruction LLC, Biomet UK Healthcare Ltd., Biomet UK Ltd., CD Diagnostics, CD Diagnostics Inc., CD Laboratories Inc., Cayenne Medical, Cayenne Medical Inc., CelgenTek Innovations Corporation, Centerpulse Ltd, Changzhou Biomet Medical Devices Co. Ltd., Citra Labs LLC, Clinical Graphics, Compression Therapy Concepts Inc., Compression Therapy Products, D.S. Comp Ltd., Dornoch Medical Systems, Dornoch Medical Systems Inc., EBI Holdings LLC, EBI LLC, EBI Medical Systems LLC, EBI Patient Care Inc., ETEX Corporation, ETEX Holdings Inc., Electro-Biology LLC, Endius, Espanormed S.L., Etex, ExtraOrtho, Hakuho Company Ltd., IC Guided Surgery SRL, Implant Concierge LLC, Implant Innovations Holdings LLC, Implex, InnoVision Inc., Interpore Cross International LLC, JERDS Luxembourg Holding Sarl, Kirschner Medical Corporation, Knee Creations, LDR Brasil Comercio Importacao e Exportacao Ltda., LDR Holding, LDR Medical Hong Kong (branch), LDR Médical S.A.S., LVB Acquisition Inc., Lanx Puerto Rico LLC , Lanx Srl, Medical Compression Systems Inc., Medtech SA, Medtech SAS, Medtech Surgical GmbH, Medtech Surgical Inc., NORMED Medizin-Technik GmbH, ORTHOsoft ULC, Ortho Transmission, Orthopaedic Advantage LLC, Ospol Participacoes Ltda., Representaciones Zimmer Inc. S. de R.L. de C.V., Respondwell, SM Re Ltd., Scandimed Holding AB, Shanghai Biomet Business Consulting Co. Ltd., Synvasive Technology, Synvasive Technology Inc., ZB COOP C.V., ZB COOP LLC, ZB Cayman (Asia) Holding Ltd., ZB Cayman Island CBT 2 Ltd., ZB Dental India Private Limited, ZB EMEA 1 LP, ZB EMEA Finance UK 1 Ltd., ZB EMEA Finance UK 2 Ltd., ZB EMEA Finance UK 3 Ltd., ZB EMEA US UK LLC, ZB Hong Kong CBT 2 Ltd., ZB Hong Kong Holding Ltd., ZB Hong Kong Ltd., ZB Manufacturing LLC, ZB UK Group Holdings Limited, ZH2LX Barbados Branch (branch), Zfx, Zfx GmbH, Zfx Innovation GmbH, Zhejiang Biomet Medical Products Co. Ltd., Zimmer (Shanghai) Medical International Trading Co. Ltd., Zimmer Asia (HK) Ltd., Zimmer Australia Holding Pty. Ltd., Zimmer Biomet (Thailand) Co. Ltd., Zimmer Biomet Asel Alarabiya Limited Company, Zimmer Biomet Asia Holding B.V., Zimmer Biomet Asia Holdings Pte. Ltd., Zimmer Biomet Austria GmbH, Zimmer Biomet BVBA, Zimmer Biomet CBT, Zimmer Biomet CBT 2, Zimmer Biomet CMF and Thoracic LLC, Zimmer Biomet Canada Inc., Zimmer Biomet Centroamerica SA, Zimmer Biomet Comp Ltd., Zimmer Biomet Denmark ApS, Zimmer Biomet Dental Canada Inc., Zimmer Biomet Dental K.K., Zimmer Biomet Deutschland GmbH, Zimmer Biomet Distribution LLC, Zimmer Biomet Finance Srl, Zimmer Biomet Finance US Holding Inc., Zimmer Biomet Finland Oy, Zimmer Biomet France Holdings SAS, Zimmer Biomet France SAS, Zimmer Biomet GK, Zimmer Biomet Global Holdings Switzerland GmbH, Zimmer Biomet Hellas SA, Zimmer Biomet Ireland Limited, Zimmer Biomet Italia Srl, Zimmer Biomet Korea Ltd., Zimmer Biomet Nederland B.V., Zimmer Biomet New Zealand Company, Zimmer Biomet Norway AS, Zimmer Biomet OUS Holdings AG, Zimmer Biomet Polska Sp. z.o.o, Zimmer Biomet Portugal Unipessoal Lda, Zimmer Biomet Pty. Ltd., Zimmer Biomet Romania S.R.L., Zimmer Biomet South Africa (Pty) Ltd., Zimmer Biomet Spain S.L., Zimmer Biomet Spine Inc., Zimmer Biomet Sweden AB, Zimmer Biomet Taiwan Co. Ltd., Zimmer Biomet UK Ltd., Zimmer Biomet US 2 Holding Inc., Zimmer CBT I Holding Inc., Zimmer CBT II Holding Inc., Zimmer CEP USA Holding Co., Zimmer CEP USA Inc., Zimmer CIS Ltd., Zimmer CV Inc., Zimmer Caribe LLC, Zimmer Cayman Islands Holding Co. Ltd., Zimmer Co-op Holdings LLC, Zimmer Colombia SAS, Zimmer Czech sro, Zimmer Dental (Shanghai) Medical Device Co. Ltd., Zimmer Dental Chile Spa, Zimmer Dental GmbH, Zimmer Dental Inc., Zimmer Dental Italy Srl, Zimmer Dental Ltd., Zimmer Dental SAS, Zimmer Finance Ireland, Zimmer France Manufacturing Sarl, Zimmer Germany Holdings GmbH, Zimmer GmbH, Zimmer GmbH Euro IP Branch (branch), Zimmer GmbH Winterthur Branch (branch), Zimmer Gulf FZ LLC, Zimmer Inc., Zimmer India Private Ltd., Zimmer International Logistics GmbH, Zimmer Investments LLC, Zimmer Knee Creations Inc., Zimmer Luxembourg II Sarl, Zimmer Luxembourg Sarl, Zimmer Manufacturing B.V., Zimmer Manufacturing B.V. (branch), Zimmer Medical Malaysia SDN BHD, Zimmer Netherlands Cooperatief U.A., Zimmer Orthobiologics Inc., Zimmer Orthopedics Manufacturing Limited, Zimmer Production Inc., Zimmer Pte. Ltd., Zimmer Slovakia sro, Zimmer Southeast Florida LLC, Zimmer Spine Next Inc., Zimmer Spine SAS, Zimmer Surgical, Zimmer Surgical Inc., Zimmer Surgical SA, Zimmer Switzerland Holdings LLC, Zimmer Switzerland Manufacturing GmbH, Zimmer Tibbi Cihazlar Sanayi ve Ticaret AS, Zimmer Trabecular Metal Technology Inc., Zimmer Trustee Ltd., Zimmer UK Limited, Zimmer US Inc., and Zimmer do Brasil Comercio Ltda.. Read More

NYSE:ZBH

Zimmer Biomet (ZBH) Stock Price, News & Analysis

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)

Free ZBH Stock Alerts

$122.97

-1.03 (-0.83%)

(As of 12:39 PM ET)

Compare

Today's Range: $121.40
▼
$124.32
50-Day Range: $121.84
▼
$132.61
52-Week Range: $102.00
▼
$149.25

Volume: 696,722 shs
Average Volume: 1.47 million shs
Market Capitalization: $25.27 billion

P/E Ratio: 25.15
Dividend Yield: 0.78%
Price Target: $139.39

Get Zimmer Biomet alerts:

Zimmer Biomet MarketRank™ Stock Analysis

Analyst Rating: Hold
2.27 Rating Score
Upside/Downside: 12.4% Upside
$139.39 Price Target
Short Interest: Healthy
2.31% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.33
Upright™ Environmental Score
News Sentiment: 1.46
Based on 6 Articles This Week
Insider Trading: Selling Shares
$3.36 M Sold Last Quarter
Proj. Earnings Growth: 7.93%
From $8.07 to $8.71 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.74 out of 5 stars

Medical Sector

56th out of 928 stocks

Surgical Appliances & Supplies Industry

1st out of 18 stocks

3.1

Analyst's Opinion

Consensus Rating
Zimmer Biomet has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 5 buy ratings, 9 hold ratings, and 1 sell rating.
Amount of Analyst Coverage
Zimmer Biomet has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
2.31% of the float of Zimmer Biomet has been sold short.
Short Interest Ratio / Days to Cover
Zimmer Biomet has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Zimmer Biomet has recently increased by 3.05%, indicating that investor sentiment is decreasing.

1.7

Dividend Strength

Dividend Yield
Zimmer Biomet has a dividend yield of 0.77%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Zimmer Biomet does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Zimmer Biomet is 19.63%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Zimmer Biomet will have a dividend payout ratio of 11.02% next year. This indicates that Zimmer Biomet will be able to sustain or increase its dividend.

3.7

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Zimmer Biomet has received a 47.23% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Dental prostheses", "Surgery simulation software", "Dental implants", and "Prostheses" products. See details.
Environmental Sustainability
The Environmental Impact score for Zimmer Biomet is -1.33.

2.5

News and Social Media Coverage

News Sentiment
Zimmer Biomet has a news sentiment score of 1.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Zimmer Biomet this week, compared to 8 articles on an average week.
Search Interest
Only 6 people have searched for ZBH on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
MarketBeat Follows
Only 8 people have added Zimmer Biomet to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Zimmer Biomet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,364,185.00 in company stock.
Percentage Held by Insiders
Only 0.70% of the stock of Zimmer Biomet is held by insiders.
Percentage Held by Institutions
88.89% of the stock of Zimmer Biomet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Zimmer Biomet are expected to grow by 7.93% in the coming year, from $8.07 to $8.71 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Zimmer Biomet is 25.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 132.07.
Price to Earnings Ratio vs. Sector
The P/E ratio of Zimmer Biomet is 25.36, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 166.67.
Price to Earnings Growth Ratio
Zimmer Biomet has a PEG Ratio of 2.29. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Zimmer Biomet has a P/B Ratio of 2.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Traders Agency

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

About Zimmer Biomet Stock (NYSE:ZBH)

Zimmer Biomet Holdings Inc is a medical technology company that designs, develops and manufactures a wide range of orthopedic and musculoskeletal products. With headquarters in Warsaw, Indiana, the company was formed in 2015 after the merger of Zimmer Holdings and Biomet Inc, two of the world's leading companies in the orthopedic industry. Zimmer Biomet's mission is to help people alleviate pain, regain mobility and improve the quality of life for patients worldwide.

The company's leadership team is led by President and CEO Bryan Hanson, who has been in his current role since 2017. Hanson has over 30 years of experience in the medical device industry and has held various executive positions in leading medical device companies. Additionally, Zimmer Biomet's executive team includes Chief Financial Officer Suketu Upadhyay and Chief Operating Officer Ivan Tornos.

Over the past few years, Zimmer Biomet has reported steady financial performance. The company has reported increased revenue and profit margin for the past several years while also reporting a debt-to-equity ratio indicating a relatively low debt level. In 2021, the company also announced a share repurchase program of up to $1 billion, demonstrating its commitment to returning value to shareholders.

Zimmer Biomet's stock performance has been mixed over the past few years. In early 2020, the company's stock price experienced a sharp decline due to the COVID-19 pandemic, but since then, it has rebounded and continues to experience volatility.

The orthopedic industry is highly competitive, with a few major players dominating the market. Zimmer Biomet is one of the largest companies in the industry, with a strong presence in the joint reconstruction, spine, dental, and sports medicine markets. The industry is also highly regulated, with various regulatory bodies overseeing the safety and efficacy of medical devices. Zimmer Biomet has a track record of complying with regulatory requirements and maintaining high-quality standards.

Zimmer Biomet is expanding its product portfolio through innovation and acquisitions. The company has a robust pipeline of new products in development, including the Persona Revision Knee System and the ROSA Knee System. Zimmer Biomet is also pursuing strategic acquisitions to expand its presence in emerging markets and strengthen its position in existing markets.

One of the most significant risks facing Zimmer Biomet is the potential for regulatory changes that could impact the industry. Changes in regulatory requirements could increase the costs and time required to bring new products to market, affecting Zimmer Biomet's ability to innovate and compete. In addition, insurance and hospital reimbursement policy changes could also impact the demand for Zimmer Biomet's products.

Another risk facing Zimmer Biomet is the potential for increased competition. While the company is one of the most significant players in the orthopedic industry, it faces competition from other established companies and new entrants. To maintain its market position, Zimmer Biomet must continue to innovate and invest in research and development.

Finally, changes in consumer preferences and healthcare trends could impact demand for Zimmer Biomet's products. For example, the increasing popularity of non-surgical treatments for orthopedic conditions could affect the demand for joint replacement products.

ZBH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ZBH Stock News Headlines

April 10, 2024 | finance.yahoo.com

The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising

April 6, 2024 | americanbankingnews.com

Research Analysts Set Expectations for Zimmer Biomet Holdings, Inc.'s Q1 2026 Earnings (NYSE:ZBH)

April 16, 2024 | Traders Agency (Ad)

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

April 4, 2024 | finance.yahoo.com

Zimmer Biomet Becomes First and Only Official Medical Device Partner of Association of Pickleball Players, Professional Pickleball Association, and USA Pickleball

April 3, 2024 | markets.businessinsider.com

Unveiling 7 Analyst Insights On Zimmer Biomet Holdings

April 3, 2024 | finance.yahoo.com

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2024 Financial Results

March 22, 2024 | finance.yahoo.com

Has Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock's Recent Performance Got Anything to Do With Its Financial Health?

March 19, 2024 | wsj.com

Zimmer Biomet Holdings Inc.

April 16, 2024 | Traders Agency (Ad)

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

March 9, 2024 | finance.yahoo.com

Insider Sell: Group President, Asia Pacific Sang Yi Sells Shares of Zimmer Biomet Holdings Inc (ZBH)

March 6, 2024 | nasdaq.com

Validea Detailed Fundamental Analysis - ZBH

March 1, 2024 | edition.cnn.com

Zimmer Biomet Holdings, Inc.

February 25, 2024 | finance.yahoo.com

Does Zimmer Biomet Holdings (NYSE:ZBH) Deserve A Spot On Your Watchlist?

February 23, 2024 | benzinga.com

Zimmer Biomet Holdings Stock (NYSE:ZBH), Analyst Ratings, Price Targets, Predictions

February 22, 2024 | markets.businessinsider.com

Zimmer Biomet Holdings: Hold Rating Maintained Amid Innovative Growth Opportunities

February 22, 2024 | markets.businessinsider.com

Zimmer Biomet Receives FDA's 510(k) Clearance For ROSA Shoulder System

February 22, 2024 | finance.yahoo.com

Zimmer Biomet Receives FDA Clearance for ROSA® Shoulder System - the World's First Robotic Assistant for Shoulder Replacement Surgery

February 22, 2024 | prnewswire.com

Zimmer Biomet Receives FDA Clearance for ROSA® Shoulder System - the World's First Robotic Assistant for Shoulder Replacement Surgery

February 21, 2024 | prnewswire.com

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2024

February 16, 2024 | markets.businessinsider.com

Zimmer Biomet Holdings: Assessing the Impact of Stabilizing Prices on Market Performance

February 14, 2024 | finance.yahoo.com

Q1 2024 Neuroone Medical Technologies Corp Earnings Call

February 12, 2024 | finance.yahoo.com

Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term

February 12, 2024 | finance.yahoo.com

Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting

February 12, 2024 | finance.yahoo.com

Zimmer Biomet Signs Global Health Equity Network's Zero Health Gaps Pledge and Expands Longstanding Commitment to Advancing Health Equity

February 11, 2024 | realmoney.thestreet.com

Zimmer Biomet price target raised by $10 at Barclays, here's why

February 11, 2024 | markets.businessinsider.com

Sell Rating on Zimmer Biomet Holdings Amid Growth and Margin Challenges

February 11, 2024 | finance.yahoo.com

Zimmer Biomet Holdings, Inc. Just Recorded A 14% EPS Beat: Here's What Analysts Are Forecasting Next

See More Headlines

Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/31 Dividend: 12/26/2023
Dividend Payable: 1/31/2024
Last Earnings: 2/08/2024
Ex-Dividend for 4/30 Dividend: 3/27/2024
Today: 4/16/2024
Dividend Payable: 4/30/2024
Next Earnings (Confirmed): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Current Symbol: NYSE:ZBH
Previous Symbol: NYSE:ZMH
CUSIP: N/A
CIK: 1136869
Web: www.zimmerbiomet.com
Phone: (574) 267-6131
Fax: 574-372-4988
Employees: 18,000
Year Founded: 1927

Price Target and Rating

Average Stock Price Target: $139.39
High Stock Price Target: $172.00
Low Stock Price Target: $120.00
Potential Upside/Downside: +12.4%
Consensus Rating: Hold
Rating Score (0-4): 2.27
Research Coverage: 15 Analysts

Profitability

EPS (Most Recent Fiscal Year): $4.89
Trailing P/E Ratio: 25.36
Forward P/E Ratio: 15.37
P/E Growth: 2.29
Net Income: $1.02 billion
Net Margins: 13.85%
Pretax Margin: 14.43%
Return on Equity: 12.79%
Return on Assets: 7.43%

Debt

Debt-to-Equity Ratio: 0.39
Current Ratio: 1.61
Quick Ratio: 0.78

Sales & Book Value

Annual Sales: $7.39 billion
Price / Sales: 3.45
Cash Flow: $12.09 per share
Price / Cash Flow: 10.26
Book Value: $59.76 per share
Price / Book: 2.07

Miscellaneous

Outstanding Shares: 205,460,000
Free Float: 204,023,000
Market Cap: $25.48 billion
Optionable: Optionable
Beta: 1.01

Social Links

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Ivan Tornos (Age 49)
COO, President, CEO & Director
Comp: $2.05M
Mr. Suketu P. Upadhyay (Age 55)
CFO and Executive VP of Finance, Operations & Supply Chain
Comp: $1.81M
Mr. Chad F. Phipps (Age 52)
Senior VP, General Counsel & Secretary
Comp: $1.23M
Mr. Sang Yi (Age 62)
President of Asia Pacific
Comp: $1.36M
Mr. Paul A. Stellato (Age 49)
VP, Controller & Chief Accounting Officer
Dr. Nitin Goyal M.D.
Chief Science, Technology & Innovation Officer
Mr. Zeeshan Tariq
Senior VP & Chief Information Officer
Ms. Keri P. Mattox
SVP and Chief Communications & Administration Officer
Mr. Zachary Ross Weiner CPA
Director of Investor Relations
Ms. Angela Main
Senior VP, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

Should I Buy Zimmer Biomet Stock? ZBH Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Zimmer Biomet Holdings, Inc.:

Zimmer Biomet Holdings, Inc. operates as a medical technology company worldwide, offering a diverse range of orthopedic reconstructive products, robotic, surgical, and bone cement products. This diversified product portfolio can provide stability and growth potential for investors.
The company serves a wide range of specialists and healthcare professionals, including orthopedic surgeons, neurosurgeons, hospitals, and healthcare dealers. This broad customer base can contribute to consistent demand for Zimmer Biomet's products.
Recent institutional investments in Zimmer Biomet Holdings, Inc. indicate confidence in the company's future prospects. For example, American Century Companies Inc. raised its stake in the company by 21.2% during the 3rd quarter, reflecting positive sentiment among institutional investors.
Wall Street analysts have provided favorable ratings for Zimmer Biomet, with some analysts giving the stock a "buy" or "market outperform" rating. Positive analyst sentiment can attract more investors and potentially drive the stock price higher.
Considering the current stock price and the company's financial performance, Zimmer Biomet Holdings, Inc. may present a value investment opportunity for investors looking for long-term growth in the surgical appliances & supplies industry.

Cons

Investors should be bearish about investing in Zimmer Biomet Holdings, Inc. for these reasons:

Despite positive analyst ratings, some analysts have issued cautious outlooks on Zimmer Biomet, such as reducing price targets. Investors should consider the potential risks associated with these cautious views before making investment decisions.
While the company has a diverse product portfolio, competition in the medical technology industry is intense. Zimmer Biomet faces competition from other established players, which could impact its market share and profitability.
Market volatility and economic uncertainties can affect the demand for medical equipment and surgical appliances. Investors should be aware of external factors that could influence Zimmer Biomet's financial performance and stock price.
Changes in healthcare regulations and policies can have a significant impact on Zimmer Biomet's operations and revenue. Investors should monitor regulatory developments closely to assess the potential risks to the company's business.
Investors should consider the overall market conditions and macroeconomic factors before investing in Zimmer Biomet Holdings, Inc. Economic downturns or industry-specific challenges could affect the company's growth prospects and stock performance.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, April 12, 2024. Please send any questions or comments about these Zimmer Biomet pros and cons to contact@marketbeat.com.

ZBH Stock Analysis - Frequently Asked Questions

Should I buy or sell Zimmer Biomet stock right now?: 15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ZBH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZBH, but not buy additional shares or sell existing shares.
View ZBH analyst ratings or view top-rated stocks.
What is Zimmer Biomet's stock price target for 2024?: 15 Wall Street research analysts have issued 12-month target prices for Zimmer Biomet's stock. Their ZBH share price targets range from $120.00 to $172.00. On average, they expect the company's share price to reach $139.39 in the next year. This suggests a possible upside of 12.4% from the stock's current price.
View analysts price targets for ZBH or view top-rated stocks among Wall Street analysts.
How have ZBH shares performed in 2024?: Zimmer Biomet's stock was trading at $121.70 at the beginning of the year. Since then, ZBH shares have increased by 1.9% and is now trading at $124.00.
View the best growth stocks for 2024 here.
When is Zimmer Biomet's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ZBH earnings forecast.
How can I listen to Zimmer Biomet's earnings call?: Zimmer Biomet will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.
How were Zimmer Biomet's earnings last quarter?: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) issued its quarterly earnings results on Thursday, February, 8th. The medical equipment provider reported $2.20 earnings per share for the quarter, beating analysts' consensus estimates of $2.15 by $0.05. The medical equipment provider earned $1.94 billion during the quarter, compared to analyst estimates of $1.93 billion. Zimmer Biomet had a net margin of 13.85% and a trailing twelve-month return on equity of 12.79%. The firm's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.88 EPS.
Read the conference call transcript.
How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?: Zimmer Biomet declared a quarterly dividend on Wednesday, February 21st. Stockholders of record on Friday, March 29th will be given a dividend of $0.24 per share on Tuesday, April 30th. This represents a $0.96 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date of this dividend is Wednesday, March 27th.
Read our dividend analysis for ZBH.
Is Zimmer Biomet a good dividend stock?: Zimmer Biomet (NYSE:ZBH) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.77%. The dividend payout ratio is 19.63%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ZBH will have a dividend payout ratio of 11.02% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ZBH.

What ETFs hold Zimmer Biomet's stock?: ETFs with the largest weight of Zimmer Biomet (NYSE:ZBH) stock in their portfolio include Leatherback Long/Short Alternative Yield ETF (LBAY), American Century Focused Large Cap Value ETF (FLV), Goldman Sachs Future Health Care Equity ETF (GDOC), VanEck Morningstar Wide Moat ETF (MOAT), Simplify Health Care ETF (PINK), iShares U.S. Medical Devices ETF (IHI), VanEck Morningstar ESG Moat ETF (MOTE) and VanEck Vectors Morningstar Global Wide Moat ETF (GOAT).
What guidance has Zimmer Biomet issued on next quarter's earnings?: Zimmer Biomet updated its FY 2024 earnings guidance on Thursday, February, 8th. The company provided EPS guidance of 8.000-8.150 for the period, compared to the consensus earnings per share estimate of 7.940. The company issued revenue guidance of $7.7 billion-$7.8 billion, compared to the consensus revenue estimate of $7.7 billion.
What is Bryan Hanson's approval rating as Zimmer Biomet's CEO?: 240 employees have rated Zimmer Biomet Chief Executive Officer Bryan Hanson on Glassdoor.com. Bryan Hanson has an approval rating of 87% among the company's employees. 66.0% of employees surveyed would recommend working at Zimmer Biomet to a friend.
What other stocks do shareholders of Zimmer Biomet own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Cisco Systems (CSCO), Merck & Co., Inc. (MRK), Intel (INTC), AbbVie (ABBV), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).
Who are Zimmer Biomet's major shareholders?: Zimmer Biomet's stock is owned by a variety of retail and institutional investors. Top institutional investors include Douglas Lane & Associates LLC (0.25%), Matrix Asset Advisors Inc. NY (0.05%), Thomasville National Bank (0.04%), ST Germain D J Co. Inc. (0.04%), Factory Mutual Insurance Co. (0.04%) and Centre Asset Management LLC (0.04%). Insiders that own company stock include Arthur J Higgins, Arthur J Higgins, Betsy J Bernard, Chad F Phipps, Michael W Michelson, Robert Hagemann, Sang Yi, Sreelakshmi Kolli and Zuilen Wilfred Van.
View institutional ownership trends.
How do I buy shares of Zimmer Biomet?: Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Zimmer Biomet have any subsidiaries?: The following companies are subsidiares of Zimmer Biomet: Abbott Spine, Beijing Montagne Medical Device Co. Ltd., Beijing Montagne Medical Device Co. Ltd., BioMet, Biomet 3i Australia Pty. Ltd., Biomet 3i Belgium N.V., Biomet 3i Benelux Holdings N.V., Biomet 3i Dental Iberica SL, Biomet 3i LLC, Biomet 3i Mexico S.A. de C.V., Biomet 3i Netherlands B.V., Biomet 3i Nordic AB, Biomet 3i Portugal Lda, Biomet 3i Switzerland GmbH, Biomet 3i Turkey, Biomet 3i UK Ltd., Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda., Biomet Acquisitions (Unlimited), Biomet Argentina SA, Biomet Australia Pty. Ltd., Biomet Biologics LLC, Biomet Brazil Medical Device Ltda., Biomet C.V., Biomet CV Holdings LLC, Biomet Cementing Technologies AB, Biomet Chile SA, Biomet China Co. Ltd., Biomet Deutschland GmbH, Biomet Deutschland Holding GmbH, Biomet Fair Lawn LLC, Biomet Finance US LLC, Biomet France Sarl, Biomet Global Supply Chain Center B.V., Biomet Healthcare Management GmbH, Biomet Holdings B.V., Biomet Hong Kong CBT Ltd., Biomet Hong Kong Holding Ltd., Biomet Hong Kong No. 1 Ltd., Biomet Inc., Biomet Insurance Ltd., Biomet International Inc., Biomet International Orthopedics LLC, Biomet Leasing Inc., Biomet Manufacturing LLC, Biomet Mexico S.A. de C.V., Biomet Microfixation B.V., Biomet Orthopedics LLC, Biomet Orthopedics Puerto Rico Inc., Biomet Spain Orthopaedics S.L., Biomet Sports Medicine LLC, Biomet Trauma LLC, Biomet U.S. Reconstruction LLC, Biomet UK Healthcare Ltd., Biomet UK Ltd., CD Diagnostics, CD Diagnostics Inc., CD Laboratories Inc., Cayenne Medical, Cayenne Medical Inc., CelgenTek Innovations Corporation, Centerpulse Ltd, Changzhou Biomet Medical Devices Co. Ltd., Citra Labs LLC, Clinical Graphics, Compression Therapy Concepts Inc., Compression Therapy Products, D.S. Comp Ltd., Dornoch Medical Systems, Dornoch Medical Systems Inc., EBI Holdings LLC, EBI LLC, EBI Medical Systems LLC, EBI Patient Care Inc., ETEX Corporation, ETEX Holdings Inc., Electro-Biology LLC, Endius, Espanormed S.L., Etex, ExtraOrtho, Hakuho Company Ltd., IC Guided Surgery SRL, Implant Concierge LLC, Implant Innovations Holdings LLC, Implex, InnoVision Inc., Interpore Cross International LLC, JERDS Luxembourg Holding Sarl, Kirschner Medical Corporation, Knee Creations, LDR Brasil Comercio Importacao e Exportacao Ltda., LDR Holding, LDR Medical Hong Kong (branch), LDR Médical S.A.S., LVB Acquisition Inc., Lanx Puerto Rico LLC , Lanx Srl, Medical Compression Systems Inc., Medtech SA, Medtech SAS, Medtech Surgical GmbH, Medtech Surgical Inc., NORMED Medizin-Technik GmbH, ORTHOsoft ULC, Ortho Transmission, Orthopaedic Advantage LLC, Ospol Participacoes Ltda., Representaciones Zimmer Inc. S. de R.L. de C.V., Respondwell, SM Re Ltd., Scandimed Holding AB, Shanghai Biomet Business Consulting Co. Ltd., Synvasive Technology, Synvasive Technology Inc., ZB COOP C.V., ZB COOP LLC, ZB Cayman (Asia) Holding Ltd., ZB Cayman Island CBT 2 Ltd., ZB Dental India Private Limited, ZB EMEA 1 LP, ZB EMEA Finance UK 1 Ltd., ZB EMEA Finance UK 2 Ltd., ZB EMEA Finance UK 3 Ltd., ZB EMEA US UK LLC, ZB Hong Kong CBT 2 Ltd., ZB Hong Kong Holding Ltd., ZB Hong Kong Ltd., ZB Manufacturing LLC, ZB UK Group Holdings Limited, ZH2LX Barbados Branch (branch), Zfx, Zfx GmbH, Zfx Innovation GmbH, Zhejiang Biomet Medical Products Co. Ltd., Zimmer (Shanghai) Medical International Trading Co. Ltd., Zimmer Asia (HK) Ltd., Zimmer Australia Holding Pty. Ltd., Zimmer Biomet (Thailand) Co. Ltd., Zimmer Biomet Asel Alarabiya Limited Company, Zimmer Biomet Asia Holding B.V., Zimmer Biomet Asia Holdings Pte. Ltd., Zimmer Biomet Austria GmbH, Zimmer Biomet BVBA, Zimmer Biomet CBT, Zimmer Biomet CBT 2, Zimmer Biomet CMF and Thoracic LLC, Zimmer Biomet Canada Inc., Zimmer Biomet Centroamerica SA, Zimmer Biomet Comp Ltd., Zimmer Biomet Denmark ApS, Zimmer Biomet Dental Canada Inc., Zimmer Biomet Dental K.K., Zimmer Biomet Deutschland GmbH, Zimmer Biomet Distribution LLC, Zimmer Biomet Finance Srl, Zimmer Biomet Finance US Holding Inc., Zimmer Biomet Finland Oy, Zimmer Biomet France Holdings SAS, Zimmer Biomet France SAS, Zimmer Biomet GK, Zimmer Biomet Global Holdings Switzerland GmbH, Zimmer Biomet Hellas SA, Zimmer Biomet Ireland Limited, Zimmer Biomet Italia Srl, Zimmer Biomet Korea Ltd., Zimmer Biomet Nederland B.V., Zimmer Biomet New Zealand Company, Zimmer Biomet Norway AS, Zimmer Biomet OUS Holdings AG, Zimmer Biomet Polska Sp. z.o.o, Zimmer Biomet Portugal Unipessoal Lda, Zimmer Biomet Pty. Ltd., Zimmer Biomet Romania S.R.L., Zimmer Biomet South Africa (Pty) Ltd., Zimmer Biomet Spain S.L., Zimmer Biomet Spine Inc., Zimmer Biomet Sweden AB, Zimmer Biomet Taiwan Co. Ltd., Zimmer Biomet UK Ltd., Zimmer Biomet US 2 Holding Inc., Zimmer CBT I Holding Inc., Zimmer CBT II Holding Inc., Zimmer CEP USA Holding Co., Zimmer CEP USA Inc., Zimmer CIS Ltd., Zimmer CV Inc., Zimmer Caribe LLC, Zimmer Cayman Islands Holding Co. Ltd., Zimmer Co-op Holdings LLC, Zimmer Colombia SAS, Zimmer Czech sro, Zimmer Dental (Shanghai) Medical Device Co. Ltd., Zimmer Dental Chile Spa, Zimmer Dental GmbH, Zimmer Dental Inc., Zimmer Dental Italy Srl, Zimmer Dental Ltd., Zimmer Dental SAS, Zimmer Finance Ireland, Zimmer France Manufacturing Sarl, Zimmer Germany Holdings GmbH, Zimmer GmbH, Zimmer GmbH Euro IP Branch (branch), Zimmer GmbH Winterthur Branch (branch), Zimmer Gulf FZ LLC, Zimmer Inc., Zimmer India Private Ltd., Zimmer International Logistics GmbH, Zimmer Investments LLC, Zimmer Knee Creations Inc., Zimmer Luxembourg II Sarl, Zimmer Luxembourg Sarl, Zimmer Manufacturing B.V., Zimmer Manufacturing B.V. (branch), Zimmer Medical Malaysia SDN BHD, Zimmer Netherlands Cooperatief U.A., Zimmer Orthobiologics Inc., Zimmer Orthopedics Manufacturing Limited, Zimmer Production Inc., Zimmer Pte. Ltd., Zimmer Slovakia sro, Zimmer Southeast Florida LLC, Zimmer Spine Next Inc., Zimmer Spine SAS, Zimmer Surgical, Zimmer Surgical Inc., Zimmer Surgical SA, Zimmer Switzerland Holdings LLC, Zimmer Switzerland Manufacturing GmbH, Zimmer Tibbi Cihazlar Sanayi ve Ticaret AS, Zimmer Trabecular Metal Technology Inc., Zimmer Trustee Ltd., Zimmer UK Limited, Zimmer US Inc., and Zimmer do Brasil Comercio Ltda..
Read More

This page (NYSE:ZBH) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Zimmer Biomet (ZBH) Stock Price, News & Analysis

Zimmer Biomet MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Zimmer Biomet Stock (NYSE:ZBH)

ZBH Stock Price History

ZBH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

Should I Buy Zimmer Biomet Stock? ZBH Pros and Cons Explained

Pros

Cons

ZBH Stock Analysis - Frequently Asked Questions

Overall MarketRank^™